These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3134309)

  • 21. Single-chain, urokinase-type plasminogen activator in a tumor model linked to metastatic potential.
    Kellen JA; Mirakian A; Wong A
    In Vivo; 1988; 2(2):155-7. PubMed ID: 2979833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
    Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells.
    Azuma M; Tamatani T; Fukui K; Yoshida H; Kamogashira T; Ogino K; Suzuki T; Sato M
    Int J Cancer; 1993 Jun; 54(4):669-76. PubMed ID: 8514458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
    Mira-y-Lopez R; Osborne MP; DePalo AJ; Ossowski L
    Int J Cancer; 1991 Apr; 47(6):827-32. PubMed ID: 1901298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of metastasis by inhibition of the urokinase receptor.
    Crowley CW; Cohen RL; Lucas BK; Liu G; Shuman MA; Levinson AD
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5021-5. PubMed ID: 8389464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator production by bovine milk macrophages and blood monocytes.
    Politis I; Zhao X; McBride BW; Burton JH; Turner JD
    Am J Vet Res; 1991 Aug; 52(8):1208-13. PubMed ID: 1928901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced plasminogen activator production of Syrian hamster embryo cells transformed by chemicals or the c-Ha-ras oncogene: type of plasminogen activators involved and their contribution to the transformed phenotype.
    de Kok AJ; Sips H; Chang GT; Verheijen JH
    Carcinogenesis; 1989 Jul; 10(7):1155-61. PubMed ID: 2500266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the plasminogen activator(s) produced by the transformed liver cell line, SK-HEP-1.
    Barlow GH; Firestone SL; Robbins KC
    Thromb Res; 1983 Oct; 32(1):29-34. PubMed ID: 6686346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
    Jankun J; Maher VM; McCormick JJ
    Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific stimulation by estradiol of tissue-type plasminogen activator production in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
    Yamashita J; Inada K; Yamashita S; Matsuo S; Nakashima Y; Ogawa M
    Horm Metab Res; 1992 Dec; 24(12):565-9. PubMed ID: 1478614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human primary colon carcinomas xenografted into nude mice. I. Characterization of plasminogen activators expressed by primary tumors and their xenografts.
    Cajot JF; Sordat B; Kruithof EK; Bachmann F
    J Natl Cancer Inst; 1986 Sep; 77(3):703-12. PubMed ID: 3091899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal and immunological characterization of the cell-associated plasminogen activators produced by cultured rat granulosa cells.
    Knecht M
    Endocrinology; 1987 May; 120(5):2174-9. PubMed ID: 3032577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
    Kirchheimer JC; Wojta J; Christ G; Binder BR
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5424-8. PubMed ID: 2501786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
    Badenoch-Jones P; Ramshaw IA; Grant A
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function.
    Wojta J; Binder BR; Huber K; Hoover RL
    Thromb Haemost; 1989 Apr; 61(2):289-93. PubMed ID: 2501899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.
    Bode C; Runge MS; Schönermark S; Eberle T; Newell JB; Kübler W; Haber E
    Circulation; 1990 Jun; 81(6):1974-80. PubMed ID: 2111744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
    Grøndahl-Hansen J; Agerlin N; Munkholm-Larsen P; Bach F; Nielsen LS; Dombernowsky P; Danø K
    J Lab Clin Med; 1988 Jan; 111(1):42-51. PubMed ID: 3121772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells.
    Gross TJ; Simon RH; Sitrin RG
    Am J Respir Cell Mol Biol; 1990 Nov; 3(5):449-56. PubMed ID: 2121171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
    Meissauer A; Kramer MD; Hofmann M; Erkell LJ; Jacob E; Schirrmacher V; Brunner G
    Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.